Survival after intensive therapy or clofarabine in fit older adults with acute myeloid leukemia: E2906 phase 3 trial.
Saved in:
| Title: | Survival after intensive therapy or clofarabine in fit older adults with acute myeloid leukemia: E2906 phase 3 trial. |
|---|---|
| Authors: | Foran JM; Division of Hematology and Medical Oncology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville, FL., Sun Z; ECOG-ACRIN Biostatistics Center, Dana-Farber Cancer Institute, Brookline, MA., Luger SM; Division of Hematology-Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Claxton DF; Penn State Cancer Institute, Penn State Milton S. Hershey Medical Center, Hershey, PA., Lazarus HM; Department of Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH., Arber DA; Department of Pathology, University of Chicago, Chicago, IL., Rowe JM; Shaare Zedek Medical Center, Jerusalem, Israel., Paietta E; ECOG-ACRIN Leukemia Translational Laboratory, Montefiore Medical Center, Bronx, NY., Racevskis J; ECOG-ACRIN Leukemia Translational Laboratory, Montefiore Medical Center, Bronx, NY., Garrett-Bakelman F; Division of Hematology and Medical Oncology, Department of Medicine, University of Virginia Cancer Center, Charlottesville, VA., Zhang Y; Memorial Sloan Kettering Cancer Center, New York, NY., Altman JK; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Al-Kali A; Division of Hematology, Mayo Clinic, Rochester, MN., Zheng H; Penn State Cancer Institute, Penn State Milton S. Hershey Medical Center, Hershey, PA., Pratz KW; Sidney Kimmel Cancer Center. Johns Hopkins University, Baltimore, MD., Broun ER; The Jewish Hospital, Cincinnati, OH., Powell BL; Department of Cancer Medicine, Wake Forest University School of Medicine, Winston-Salem, NC., O'Dwyer KM; Division of Hematology and Oncology, Department of Medicine, University of Rochester School of Medicine, Rochester, NY., Godwin JE; Providence Portland Medical Center, Portland, OR., Ofran Y; Shaare Zedek Medical Center, Jerusalem, Israel., Litzow MR; Division of Hematology, Mayo Clinic, Rochester, MN., Tallman MS; Memorial Sloan Kettering Cancer Center, New York, NY. |
| Source: | Blood neoplasia [Blood Neoplasia] 2026 Jan 14; Vol. 3 (2), pp. 100194. Date of Electronic Publication: 2026 Jan 14 (Print Publication: 2026). |
| Publication Type: | Clinical Trial; Journal Article |
| Journal Info: | Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 9918841988906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2950-3280 (Electronic) Linking ISSN: 29503280 NLM ISO Abbreviation: Blood Neoplasia Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
